Bristol-Myers Squibb Ownership | Who Owns Bristol-Myers Squibb?
Bristol-Myers Squibb Ownership Summary
Bristol-Myers Squibb is owned by 80.44% institutional investors, 0.08% insiders, and 19.49% retail investors. Vanguard group is the largest institutional shareholder, holding 9.63% of BMY shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.16% of its assets in Bristol-Myers Squibb shares.
BMY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bristol-Myers Squibb | 80.44% | 0.08% | 19.49% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Drug Manufacturers - General Stocks | 50.22% | 2.50% | 47.29% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 195.98M | 9.63% | $8.84B |
| Blackrock funding, inc. /de | 175.52M | 8.62% | $7.92B |
| Blackrock | 158.66M | 7.84% | $6.59B |
| State street | 95.14M | 4.69% | $5.38B |
| Jpmorgan chase | 86.18M | 4.23% | $3.89B |
| Charles schwab investment management | 73.04M | 3.59% | $3.29B |
| Geode capital management | 46.55M | 2.29% | $2.10B |
| Norges bank | 35.18M | 1.73% | $1.99B |
| Capital investors | 32.39M | 1.59% | $1.46B |
| Ameriprise financial | 32.08M | 1.58% | $1.81B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Chiron capital management | 286.41K | 11.54% | $13.26M |
| Birchview capital, lp | 316.84K | 10.79% | $14.29M |
| Optimas capital | 255.50K | 7.29% | $11.52M |
| Sector gamma as | 581.27K | 6.50% | $26.22M |
| Independent franchise partners llp | 20.62M | 6.13% | $930.11M |
| Colrain capital | 178.03K | 4.57% | $8.03M |
| Oaktop capital management ii | 479.99K | 3.39% | $27.15M |
| Fulcrum asset management llp | 26.93K | 2.83% | $908.59K |
| Keene & associates | 61.88K | 2.81% | $3.50M |
| Nepsis | 183.30K | 2.62% | $8.27M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 35.18M | 0.26% | 35.18M |
| Ameriprise financial | 32.08M | 0.47% | 12.01M |
| Qube research | 9.75M | 0.46% | 9.75M |
| Van eck associates | 9.86M | 0.41% | 5.93M |
| Wellington management group llp | 5.98M | 0.06% | 5.83M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | 32.39M | 0.24% | -33.78M |
| Jpmorgan chase | 86.18M | 0.23% | -17.78M |
| Price t rowe associates inc /md/ | 7.53M | 0.05% | -12.71M |
| Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main | 5.81M | 0.27% | -11.27M |
| Two sigma advisers, lp | 1.86M | 0.24% | -7.69M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 35.18M | 0.26% | 35.18M | $1.99B |
| Qube research | 9.75M | 0.46% | 9.75M | $451.45M |
| Capitolis liquid global markets | 939.20K | 0.32% | 939.20K | $43.48M |
| Fjarde ap-fonden (the fourth swedish national pensionfund) | 474.01K | 0.22% | 474.01K | $19.68M |
| Foundry partners | 406.68K | 1.16% | 406.68K | $23.00M |
Sold Out
| Holder | Change |
|---|---|
| Hwg lp | -1.00 |
| Wiser advisor group | -1.00 |
| Macroview investment management | -1.00 |
| Aspect partners | -6.00 |
| Goalvest advisory | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 2,329 | -8.02% | 1,636,868,808 | 2.69% | 80 | 1.31% | 939 | -18.35% | 1,028 | 5.01% |
| Mar 31, 2025 | 2,494 | -1.46% | 1,588,605,053 | -0.15% | 78 | 1.27% | 1,137 | -10.26% | 963 | 5.02% |
| Dec 31, 2024 | 2,418 | 4.18% | 1,585,430,555 | 4.93% | 78 | 1.41% | 1,203 | 11.49% | 880 | -2.98% |
| Sep 30, 2024 | 2,292 | 4.13% | 1,507,866,452 | -1.64% | 74 | 1.30% | 1,070 | 26.48% | 890 | -14.18% |
| Jun 30, 2024 | 2,162 | -9.39% | 1,529,042,503 | 0.24% | 75 | 1.33% | 830 | -23.85% | 1,020 | 6.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 64.21M | 3.16% | 47.00K |
| Vanguard Total Stock Mkt Idx Inv | 63.97M | 3.14% | -1.47M |
| Vanguard Institutional 500 Index Trust | 57.72M | 2.84% | 399.61K |
| Schwab US Dividend Equity ETF™ | 56.74M | 2.79% | 12.00K |
| Vanguard 500 Index Investor | 50.38M | 2.47% | -7.38M |
| Fidelity 500 Index | 25.80M | 1.27% | 11.09K |
| SPDR® S&P 500 ETF | 25.22M | 1.24% | -369.06K |
| SPDR® S&P 500® ETF | 24.56M | 1.21% | 302.33K |
| SPDR® S&P 500® ETF Trust | 24.55M | 1.21% | -128.84K |
| iShares Core S&P 500 ETF | 24.49M | 1.20% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 02, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | $2.65M |
| Aug 02, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | $16.72K |
| May 09, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | $3.70K |
| Apr 25, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | $202.22K |
| Feb 20, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Buy | $110.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | 2 |
| 2025 Q2 | 1 | 1 |
| 2025 Q1 | 2 | - |
| 2024 Q4 | 1 | 1 |
BMY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools